Hypergraph learning for identification of COVID-19 with CT imaging.

Journal: Medical image analysis
Published Date:

Abstract

The coronavirus disease, named COVID-19, has become the largest global public health crisis since it started in early 2020. CT imaging has been used as a complementary tool to assist early screening, especially for the rapid identification of COVID-19 cases from community acquired pneumonia (CAP) cases. The main challenge in early screening is how to model the confusing cases in the COVID-19 and CAP groups, with very similar clinical manifestations and imaging features. To tackle this challenge, we propose an Uncertainty Vertex-weighted Hypergraph Learning (UVHL) method to identify COVID-19 from CAP using CT images. In particular, multiple types of features (including regional features and radiomics features) are first extracted from CT image for each case. Then, the relationship among different cases is formulated by a hypergraph structure, with each case represented as a vertex in the hypergraph. The uncertainty of each vertex is further computed with an uncertainty score measurement and used as a weight in the hypergraph. Finally, a learning process of the vertex-weighted hypergraph is used to predict whether a new testing case belongs to COVID-19 or not. Experiments on a large multi-center pneumonia dataset, consisting of 2148 COVID-19 cases and 1182 CAP cases from five hospitals, are conducted to evaluate the prediction accuracy of the proposed method. Results demonstrate the effectiveness and robustness of our proposed method on the identification of COVID-19 in comparison to state-of-the-art methods.

Authors

  • Donglin Di
    BNRist, THUIBCS, KLISS, School of Software, Tsinghua University, Beijing, China.
  • Feng Shi
    Department of Research and Development, Shanghai United Imaging Intelligence, Co., Ltd. Shanghai, China.
  • Fuhua Yan
    Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No.197 Ruijin Er Road, Shanghai 200025, China. Electronic address: yfh11655@rjh.com.cn.
  • Liming Xia
    From the Department of Radiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands (Q.T., E.H.M.P., D.P.S., A.d.R., H.J.L., R.J.v.d.G.); Department of Electrical Engineering, Fudan University, Shanghai, China (W.Y., Y.W.); Multidisciplinary Cardiovascular Research Centre & Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, England (P.G., S.P.); Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China (L.H., L.X.); and Departments of Cardiology (M.S.) and Radiology (J.T.), Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
  • Zhanhao Mo
  • Zhongxiang Ding
  • Fei Shan
    Gastrointestinal Cancer Center, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China.
  • Bin Song
    Department of Radiology, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Shengrui Li
    BNRist, THUIBCS, KLISS, School of Software, Tsinghua University, Beijing, China.
  • Ying Wei
    School of Information Science and Engineering, Northeastern University, Shenyang 110004, China ; Key Laboratory of Medical Imaging Calculation of the Ministry of Education, Shenyang 110004, China.
  • Ying Shao
  • Miaofei Han
    Department of Research and Development, Shanghai United Imaging Intelligence Co., Ltd., Shanghai, China.
  • Yaozong Gao
  • He Sui
  • Yue Gao
    Institute of Medical Technology, Peking University Health Science Center, Beijing, China.
  • Dinggang Shen
    School of Biomedical Engineering, ShanghaiTech University, Shanghai, China.